← Back
$JANX All transactions

Janux Therapeutics, Inc.

A

$ Value

$0

Shares

28,600

Price

$0

Filed

Jan 2

Insider

Name

Winter Charles M.

Title

Chief Technical Officer

CIK

0001960264

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

106,321

Footnotes

The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units. | Includes 2,834 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 15, 2025. | Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027. | 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

Filing Info

Accession No.

0001960264-26-000002

Form Type

4

Issuer CIK

0001817713

Winter Charles M.'s History

Date Ticker Type Value
2026-01-02 JANX $33K
2026-01-02 JANX A $0
2026-01-02 JANX A $0

Other Insiders at JANX (90d)

Insider Bought Sold Last
Go William
Chief Medical Officer
2026-02-02